Bristol-Myers Squibb Co vs Pinterest Inc — how do they compare? Bristol-Myers Squibb Co trades at $58.53 (market cap $116.30B), while Pinterest Inc trades at $23.43 (market cap $12.66B). The key difference: Bristol-Myers Squibb Co is far larger — about 9.2× Pinterest Inc's market cap, and Bristol-Myers Squibb Co pays a 4.42% dividend while Pinterest Inc pays none. Which is the better fit depends on your goals.
| BMY | PINS | |
|---|---|---|
Market Cap | $116.30B | $12.66B |
Sector | Health | Media |
52-Week High | $62.37 | $39.17 |
52-Week Low | $42.60 | $15.42 |
Enterprise Value | $152.24B | $12.57B |
Dividend Yield | 4.42% | — |
Signals from Pluang's Aura AI — not financial advice
Bristol Myers Squibb (BMY) trades at $59.34, up 3.06% today, with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with a 15.01% net margin and 38.84% ROE, though debt levels have risen. Recent FDA acceptance for mezigdomide in multiple myeloma highlights pipeline progress. Analysts are mixed with a $60 consensus target, slightly above current price.
BMY offers value with a P/E of 16.62 and a safe 4.3% dividend yield, but faces patent cliff risks and pricing pressures. Earnings growth and pipeline execution are key catalysts, while high debt and competitive threats require monitoring. The stock presents a balanced opportunity for income-focused investors with moderate risk tolerance.
Pinterest (PINS) trades at $22.6, up 0.31% on the day, with a bullish technical outlook and strong analyst consensus. Revenue grew to $4.22B in 2025, with net income of $417M, though Q2 2026 earnings are pending. Recent news highlights AI-driven shopping features and user growth, supporting positive sentiment.
The stock offers upside to the $27.72 consensus target, but high valuation ratios and recent insider selling pose risks. Earnings consistency and competitive pressures in social media remain key watchpoints for investors.
Trailing returns across standard periods
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →Pinterest is an online product and idea discovery platform that helps users gather ideas on everything from recipes to cook to destinations to travel to. Founded in 2010, the platform consists of a largely female audience, at roughly two thirds of its more than 365 million monthly active users. The company generates revenue by selling digital ads and is now rolling out more in-platform e-commerce features.
Read more on PINS →